Compare ARK Genomic Revolution ETF (ARKG) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco Preferred ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Invesco Preferred ETF trades at $10.68. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | PGX | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $11.87 |
52-Week Low | $24.02 | $10.65 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $44.49, up 0.41% today, with a bullish technical bias from moving averages but overbought RSI signals. The ETF focuses on genomic revolution stocks, with top 10 holdings comprising 59% of assets and a long-term EPS growth rate of 10.7% (Seeking Alpha, 2026-07-28). Recent news highlights biotech sector strength driven by FDA friendliness and AI-driven drug discovery.
Outlook is cautiously optimistic given sector tailwinds, but high concentration and volatility pose risks. The ETF's exposure to small- and mid-cap biotech offers growth potential, yet investors face regulatory and market sentiment shifts. Near-term performance may hinge on broader tech trends and biotech M&A activity.
PGX trades at $10.675, up 0.23% today, with a bearish technical signal driven by moving averages. Key financial ratios are unavailable, but the company has declared dividends for H1-26 and H2-26. Recent news includes an article on preferred ETFs and a project sale by Prosper Gold Corp., though the latter may not directly relate to the US-listed entity.
The outlook is cautious due to bearish technicals and lack of fundamental data. Risks include potential misidentification with other entities and limited financial transparency. Investment appeal hinges on future earnings clarity and sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
